3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
13
Gastrointestinal Stromal Tumors
12
Leukemia, Myeloid, Chronic-Phase
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia
3
Neoplasms
2
Melanoma
2
Burkitt Lymphoma
2
Uveal Melanoma
1
Triple Negative Breast Neoplasms
1
Thyroid Cancer, Papillary
1
Squamous Cell Carcinoma of Head and Neck
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
1
Philadelphia Chromosome
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Lymphangioleiomyomatosis
1
Leukemia, Myeloid
1
Leukemia, Biphenotypic, Acute
1
Hypereosinophilic Syndrome
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
Graft vs Host Disease
1
Digestive System Neoplasms
1
Desmoid Tumors
1
Dermatofibrosarcoma
1
Congenital Bone Marrow Failure Syndromes
1
Chordoma
1
Carcinoma, Adenoid Cystic
1
Interventions
Methylprednisolone
3
Social Determinants of Health
2
trastuzumab deruxtecan
1
sacituzumab govitecan
1
pegaspargase
1
Vincristine
1
Temozolomide
1
Radiotherapy
1
Prednisone
1
Prednisolone
1
Pharmaceutical Services
1
Methylprednisolone Hemisuccinate
1
Methotrexate
1
Mercaptopurine
1
Leucovorin
1
Irinotecan
1
Infliximab
1
Hydrocortisone
1
Fecal Microbiota Transplantation
1
Etoposide
1
Drug Therapy
1
Doxorubicin
1
Dexrazoxane
1
Dexamethasone
1
Cytarabine
1
Cyclophosphamide
1
Cefixime
1
CTLA-4 Antigen
1
Asparaginase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Drug-Related Side Effects and Adverse Reactions
×
Imatinib Mesylate
×
1 year
×
Clear all
No trials found.